Sulfonylureas and basal insulin linked to elevated cardiovascular risk

Sulfonylureas and basal insulin confer an increased risk of cardiovascular events compared with newer second-line medicines for type 2 diabetes mellitus, research has found.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research